HROW
Harrow Health Inc
Halal Rating :
Last Price
$33.84
Last updated:
Market Cap
-
7D Change
-2.59%
1 Year Change
246.37%
Company Overview
Industries
Exchange
Next Earnings Date
Harrow Health Inc. is a commercial-stage eyecare pharmaceutical company that develops, produces, and sells prescription pharmaceuticals used in ophthalmic surgery, the treatment of ophthalmic diseases, and other healthcare areas. The company's primary focus is on developing and commercializing innovative pharmaceutical products for the eye care sector.
Use of Interest
| Reporting Date | Total Revenue | Total Operating Expense | Interest Income | Interest Expense | Interest Income Ratio | Interest Expense Ratio |
|---|---|---|---|---|---|---|
| Sept. 30, 2024 | $49.26m | $53.46m | - | $5.53m | 0.00% | 10.33% |
| June 30, 2024 | $48.94m | $52.88m | - | $5.47m | 0.00% | 10.35% |
| March 31, 2024 | $34.59m | $46.93m | - | $5.42m | 0.00% | 11.54% |
Company Impact
Help us evaluate Harrow Health Inc's impact from a halal perspective. Vote on the most significant aspect and submit any considerations that we may have missed.